Table of Content

1 Prescription Dermatological Drugs Market Overview
1.1 Prescription Dermatological Drugs Product Scope
1.2 Prescription Dermatological Drugs Segment by Type
1.2.1 Global Prescription Dermatological Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Anti-acne Drugs
1.2.3 Anti-aging Drugs
1.2.4 Dermatitis Drugs
1.2.5 Hair Loss Drugs
1.2.6 Psoriasis Drugs
1.2.7 Skin Cancer Drugs
1.2.8 Melasma Drugs
1.2.9 Seborrhea Drugs
1.3 Prescription Dermatological Drugs Segment by Application
1.3.1 Global Prescription Dermatological Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Prescription Dermatological Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Prescription Dermatological Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Prescription Dermatological Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Prescription Dermatological Drugs Price Trends (2016-2027)

2 Prescription Dermatological Drugs Estimates and Forecasts by Region
2.1 Global Prescription Dermatological Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Prescription Dermatological Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Prescription Dermatological Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Prescription Dermatological Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Prescription Dermatological Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Prescription Dermatological Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Prescription Dermatological Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Prescription Dermatological Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Prescription Dermatological Drugs Estimates and Projections (2016-2027)
2.4.3 China Prescription Dermatological Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Prescription Dermatological Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Prescription Dermatological Drugs Estimates and Projections (2016-2027)
2.4.6 India Prescription Dermatological Drugs Estimates and Projections (2016-2027)

3 Global Prescription Dermatological Drugs Competition Landscape by Players
3.1 Global Top Prescription Dermatological Drugs Players by Sales (2016-2021)
3.2 Global Top Prescription Dermatological Drugs Players by Revenue (2016-2021)
3.3 Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prescription Dermatological Drugs as of 2020)
3.4 Global Prescription Dermatological Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Prescription Dermatological Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Prescription Dermatological Drugs Market Size by Type
4.1 Global Prescription Dermatological Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Prescription Dermatological Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Prescription Dermatological Drugs Price by Type (2016-2021)
4.2 Global Prescription Dermatological Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Prescription Dermatological Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Prescription Dermatological Drugs Price Forecast by Type (2022-2027)

5 Global Prescription Dermatological Drugs Market Size by Application
5.1 Global Prescription Dermatological Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Prescription Dermatological Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Prescription Dermatological Drugs Price by Application (2016-2021)
5.2 Global Prescription Dermatological Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Prescription Dermatological Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Prescription Dermatological Drugs Price Forecast by Application (2022-2027)

6 North America Prescription Dermatological Drugs Market Facts & Figures
6.1 North America Prescription Dermatological Drugs Sales by Company
6.1.1 North America Prescription Dermatological Drugs Sales by Company (2016-2021)
6.1.2 North America Prescription Dermatological Drugs Revenue by Company (2016-2021)
6.2 North America Prescription Dermatological Drugs Sales Breakdown by Type
6.2.1 North America Prescription Dermatological Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Prescription Dermatological Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Prescription Dermatological Drugs Sales Breakdown by Application
6.3.1 North America Prescription Dermatological Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Prescription Dermatological Drugs Sales Breakdown by Application (2022-2027)

7 Europe Prescription Dermatological Drugs Market Facts & Figures
7.1 Europe Prescription Dermatological Drugs Sales by Company
7.1.1 Europe Prescription Dermatological Drugs Sales by Company (2016-2021)
7.1.2 Europe Prescription Dermatological Drugs Revenue by Company (2016-2021)
7.2 Europe Prescription Dermatological Drugs Sales Breakdown by Type
7.2.1 Europe Prescription Dermatological Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Prescription Dermatological Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Prescription Dermatological Drugs Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)

8 China Prescription Dermatological Drugs Market Facts & Figures
8.1 China Prescription Dermatological Drugs Sales by Company
8.1.1 China Prescription Dermatological Drugs Sales by Company (2016-2021)
8.1.2 China Prescription Dermatological Drugs Revenue by Company (2016-2021)
8.2 China Prescription Dermatological Drugs Sales Breakdown by Type
8.2.1 China Prescription Dermatological Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Prescription Dermatological Drugs Sales Breakdown by Type (2022-2027)
8.3 China Prescription Dermatological Drugs Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)

9 Japan Prescription Dermatological Drugs Market Facts & Figures
9.1 Japan Prescription Dermatological Drugs Sales by Company
9.1.1 Japan Prescription Dermatological Drugs Sales by Company (2016-2021)
9.1.2 Japan Prescription Dermatological Drugs Revenue by Company (2016-2021)
9.2 Japan Prescription Dermatological Drugs Sales Breakdown by Type
9.2.1 Japan Prescription Dermatological Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Prescription Dermatological Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Prescription Dermatological Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Prescription Dermatological Drugs Market Facts & Figures
10.1 Southeast Asia Prescription Dermatological Drugs Sales by Company
10.1.1 Southeast Asia Prescription Dermatological Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Prescription Dermatological Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Prescription Dermatological Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Prescription Dermatological Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Prescription Dermatological Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Prescription Dermatological Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Prescription Dermatological Drugs Market Facts & Figures
11.1 India Prescription Dermatological Drugs Sales by Company
11.1.1 India Prescription Dermatological Drugs Sales by Company (2016-2021)
11.1.2 India Prescription Dermatological Drugs Revenue by Company (2016-2021)
11.2 India Prescription Dermatological Drugs Sales Breakdown by Type
11.2.1 India Prescription Dermatological Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Prescription Dermatological Drugs Sales Breakdown by Type (2022-2027)
11.3 India Prescription Dermatological Drugs Sales Breakdown by Application
11.3.1 India Prescription Dermatological Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Prescription Dermatological Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Prescription Dermatological Drugs Business
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Business Overview
12.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Prescription Dermatological Drugs Products Offered
12.2.5 Merck Recent Development
12.3 LEO Pharma
12.3.1 LEO Pharma Corporation Information
12.3.2 LEO Pharma Business Overview
12.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 LEO Pharma Prescription Dermatological Drugs Products Offered
12.3.5 LEO Pharma Recent Development
12.4 Mylan Pharmaceuticals
12.4.1 Mylan Pharmaceuticals Corporation Information
12.4.2 Mylan Pharmaceuticals Business Overview
12.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Products Offered
12.4.5 Mylan Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Prescription Dermatological Drugs Products Offered
12.5.5 Pfizer Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Business Overview
12.6.3 Roche Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Roche Prescription Dermatological Drugs Products Offered
12.6.5 Roche Recent Development
12.7 Allergan
12.7.1 Allergan Corporation Information
12.7.2 Allergan Business Overview
12.7.3 Allergan Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Allergan Prescription Dermatological Drugs Products Offered
12.7.5 Allergan Recent Development
12.8 Bausch Health
12.8.1 Bausch Health Corporation Information
12.8.2 Bausch Health Business Overview
12.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bausch Health Prescription Dermatological Drugs Products Offered
12.8.5 Bausch Health Recent Development
12.9 PharmaDerm Pharmaceuticals
12.9.1 PharmaDerm Pharmaceuticals Corporation Information
12.9.2 PharmaDerm Pharmaceuticals Business Overview
12.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Products Offered
12.9.5 PharmaDerm Pharmaceuticals Recent Development
12.10 Allergan Inamed Corporation
12.10.1 Allergan Inamed Corporation Corporation Information
12.10.2 Allergan Inamed Corporation Business Overview
12.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Products Offered
12.10.5 Allergan Inamed Corporation Recent Development

13 Prescription Dermatological Drugs Manufacturing Cost Analysis
13.1 Prescription Dermatological Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Prescription Dermatological Drugs
13.4 Prescription Dermatological Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Prescription Dermatological Drugs Distributors List
14.3 Prescription Dermatological Drugs Customers

15 Market Dynamics
15.1 Prescription Dermatological Drugs Market Trends
15.2 Prescription Dermatological Drugs Drivers
15.3 Prescription Dermatological Drugs Market Challenges
15.4 Prescription Dermatological Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Prescription Dermatological Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Prescription Dermatological Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Prescription Dermatological Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Prescription Dermatological Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Prescription Dermatological Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Prescription Dermatological Drugs Revenue Share by Region (2016-2021)
Table 8. Global Prescription Dermatological Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Prescription Dermatological Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Prescription Dermatological Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Prescription Dermatological Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Prescription Dermatological Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Prescription Dermatological Drugs Sales Share by Company (2016-2021)
Table 14. Global Prescription Dermatological Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Prescription Dermatological Drugs Revenue Share by Company (2016-2021)
Table 16. Global Prescription Dermatological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatological Drugs as of 2020)
Table 17. Global Prescription Dermatological Drugs Average Price (USD/Units) of Key Company (2016-2021)
Table 18. Manufacturers Prescription Dermatological Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Prescription Dermatological Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Prescription Dermatological Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Prescription Dermatological Drugs Sales Share by Type (2016-2021)
Table 23. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Prescription Dermatological Drugs Price (USD/Units) by Type (2016-2021)
Table 25. Global Prescription Dermatological Drugs Sales Share by Type (2022-2027)
Table 26. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Prescription Dermatological Drugs Revenue Share by Type (2022-2027)
Table 28. Global Prescription Dermatological Drugs Price (USD/Units) by Type (2022-2027)
Table 29. Global Prescription Dermatological Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Prescription Dermatological Drugs Sales Share by Application (2016-2021)
Table 31. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Prescription Dermatological Drugs Price (USD/Units) by Application (2016-2021)
Table 33. Global Prescription Dermatological Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Prescription Dermatological Drugs Sales Share by Application (2022-2027)
Table 35. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Prescription Dermatological Drugs Revenue Share by Application (2022-2027)
Table 37. Global Prescription Dermatological Drugs Price (USD/Units) by Application (2022-2027)
Table 38. North America Prescription Dermatological Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Prescription Dermatological Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Prescription Dermatological Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Prescription Dermatological Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Prescription Dermatological Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Prescription Dermatological Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Prescription Dermatological Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Prescription Dermatological Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Prescription Dermatological Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Prescription Dermatological Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Prescription Dermatological Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Prescription Dermatological Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Prescription Dermatological Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Prescription Dermatological Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Prescription Dermatological Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Prescription Dermatological Drugs Sales Market Share by Application (2022-2027)
Table 62. China Prescription Dermatological Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Prescription Dermatological Drugs Sales Market Share by Company (2016-2021)
Table 64. China Prescription Dermatological Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Prescription Dermatological Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 68. China Prescription Dermatological Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Prescription Dermatological Drugs Sales Market Share by Type (2022-2027)
Table 70. China Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 72. China Prescription Dermatological Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Prescription Dermatological Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Prescription Dermatological Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Prescription Dermatological Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Prescription Dermatological Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Prescription Dermatological Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Prescription Dermatological Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Prescription Dermatological Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Prescription Dermatological Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Prescription Dermatological Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Prescription Dermatological Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Prescription Dermatological Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Prescription Dermatological Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Prescription Dermatological Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Prescription Dermatological Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Prescription Dermatological Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Prescription Dermatological Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Prescription Dermatological Drugs Sales Market Share by Application (2022-2027)
Table 98. India Prescription Dermatological Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Prescription Dermatological Drugs Sales Market Share by Company (2016-2021)
Table 100. India Prescription Dermatological Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Prescription Dermatological Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 104. India Prescription Dermatological Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Prescription Dermatological Drugs Sales Market Share by Type (2022-2027)
Table 106. India Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 108. India Prescription Dermatological Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Prescription Dermatological Drugs Sales Market Share by Application (2022-2027)
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 113. Johnson & Johnson Prescription Dermatological Drugs Product
Table 114. Johnson & Johnson Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 118. Merck Prescription Dermatological Drugs Product
Table 119. Merck Recent Development
Table 120. LEO Pharma Corporation Information
Table 121. LEO Pharma Description and Business Overview
Table 122. LEO Pharma Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 123. LEO Pharma Prescription Dermatological Drugs Product
Table 124. LEO Pharma Recent Development
Table 125. Mylan Pharmaceuticals Corporation Information
Table 126. Mylan Pharmaceuticals Description and Business Overview
Table 127. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 128. Mylan Pharmaceuticals Prescription Dermatological Drugs Product
Table 129. Mylan Pharmaceuticals Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 133. Pfizer Prescription Dermatological Drugs Product
Table 134. Pfizer Recent Development
Table 135. Roche Corporation Information
Table 136. Roche Description and Business Overview
Table 137. Roche Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 138. Roche Prescription Dermatological Drugs Product
Table 139. Roche Recent Development
Table 140. Allergan Corporation Information
Table 141. Allergan Description and Business Overview
Table 142. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 143. Allergan Prescription Dermatological Drugs Product
Table 144. Allergan Recent Development
Table 145. Bausch Health Corporation Information
Table 146. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 147. Bausch Health Description and Business Overview
Table 148. Bausch Health Prescription Dermatological Drugs Product
Table 149. Bausch Health Recent Development
Table 150. PharmaDerm Pharmaceuticals Corporation Information
Table 151. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 152. PharmaDerm Pharmaceuticals Description and Business Overview
Table 153. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product
Table 154. PharmaDerm Pharmaceuticals Recent Development
Table 155. Allergan Inamed Corporation Corporation Information
Table 156. Allergan Inamed Corporation Description and Business Overview
Table 157. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2016-2021)
Table 158. Allergan Inamed Corporation Prescription Dermatological Drugs Product
Table 159. Allergan Inamed Corporation Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Prescription Dermatological Drugs Distributors List
Table 163. Prescription Dermatological Drugs Customers List
Table 164. Prescription Dermatological Drugs Market Trends
Table 165. Prescription Dermatological Drugs Market Drivers
Table 166. Prescription Dermatological Drugs Market Challenges
Table 167. Prescription Dermatological Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Prescription Dermatological Drugs Product Picture
Figure 2. Global Prescription Dermatological Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Anti-acne Drugs Product Picture
Figure 4. Anti-aging Drugs Product Picture
Figure 5. Dermatitis Drugs Product Picture
Figure 6. Hair Loss Drugs Product Picture
Figure 7. Psoriasis Drugs Product Picture
Figure 8. Skin Cancer Drugs Product Picture
Figure 9. Melasma Drugs Product Picture
Figure 10. Seborrhea Drugs Product Picture
Figure 11. Global Prescription Dermatological Drugs Sales Market Share by Application in 2021 & 2027
Figure 12. Hospital Pharmacies Examples
Figure 13. Retail Pharmacies Examples
Figure 14. Online Pharmacies Examples
Figure 15. Global Prescription Dermatological Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Prescription Dermatological Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 17. Global Prescription Dermatological Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 18. Global Prescription Dermatological Drugs Price Trends Growth Rate (2016-2027) (USD/Units)
Figure 19. Global Prescription Dermatological Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 20. Global Prescription Dermatological Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 21. North America Prescription Dermatological Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. North America Prescription Dermatological Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 23. Europe Prescription Dermatological Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Europe Prescription Dermatological Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. China Prescription Dermatological Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. China Prescription Dermatological Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 27. Japan Prescription Dermatological Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Japan Prescription Dermatological Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Prescription Dermatological Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia Prescription Dermatological Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 31. India Prescription Dermatological Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 32. India Prescription Dermatological Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 33. Global 5 Largest Prescription Dermatological Drugs Players Market Share by Revenue in Prescription Dermatological Drugs: 2016 & 2020
Figure 34. Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 35. Global Prescription Dermatological Drugs Revenue Share by Type (2016-2021)
Figure 36. Global Prescription Dermatological Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Global Prescription Dermatological Drugs Revenue Share by Application (2016-2021)
Figure 38. Global Prescription Dermatological Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 40. North America Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 41. Europe Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 42. Europe Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 43. China Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 44. China Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 45. Japan Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 46. Japan Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 47. Southeast Asia Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 48. Southeast Asia Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 49. India Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 50. India Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Prescription Dermatological Drugs
Figure 53. Manufacturing Process Analysis of Prescription Dermatological Drugs
Figure 54. Prescription Dermatological Drugs Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed